Next Article in Journal
Nanoparticles Design for Theranostic Approach in Cancer Disease
Next Article in Special Issue
A New Source of Heterogeneity in Comparative and Translational Clinical Trials: The “Border-Time” Bias
Previous Article in Journal
Combined Large Cell Neuroendocrine Carcinomas of the Lung: Integrative Molecular Analysis Identifies Subtypes with Potential Therapeutic Implications
Previous Article in Special Issue
Multi-Omics Analysis of GNL3L Expression, Prognosis, and Immune Value in Pan-Cancer
 
 
Review

Article Versions Notes

Cancers 2022, 14(19), 4655; https://doi.org/10.3390/cancers14194655
Action Date Notes Link
article pdf uploaded. 24 September 2022 16:19 CEST Version of Record https://www.mdpi.com/2072-6694/14/19/4655/pdf-vor
article xml file uploaded 29 September 2022 16:43 CEST Original file -
article xml uploaded. 29 September 2022 16:43 CEST Update https://www.mdpi.com/2072-6694/14/19/4655/xml
article pdf uploaded. 29 September 2022 16:43 CEST Updated version of record https://www.mdpi.com/2072-6694/14/19/4655/pdf
article html file updated 29 September 2022 16:44 CEST Original file -
article html file updated 30 September 2022 10:00 CEST Update -
article html file updated 28 February 2023 15:11 CET Update https://www.mdpi.com/2072-6694/14/19/4655/html
Back to TopTop